RT_Image: An Open-Source Tool for Investigating PET in Radiation Oncology

Positron emission tomography (PET) has emerged as a valuable imaging modality for the diagnosis and staging of cancer. However, despite evidence that PET may be useful for defining target volumes for radiation therapy, no standardized methodology for accomplishing this task exists. To facilitate the investigation of the utility of PET imaging in radiotherapy treatment planning and accelerate its integration into clinical radiation oncology, we have developed software for exploratory analysis and segmentation of functional imaging datasets. The application, RT_Image, allows display of multiple imaging datasets and associated three-dimensional regions-of-interest (ROIs) at arbitrary view angles and fields of view. It also includes semi-automated image segmentation tools for defining metabolically active tumor volumes that may aid creation of target volumes for treatment planning. RT_Image is DICOM compliant, permitting the transfer of imaging data and DICOM-RT structure sets between the application and treatment planning software. RT_Image has been used by radiation oncologists, nuclear medicine physicians, and radiation physicists to analyze over 200 PET datasets. Novel segmentation techniques have been implemented within this programming framework for therapy planning and for evaluation of molecular imaging-derived parameters as prognostic indicators. RT_Image represents a freely-available software base on which further investigations of the utlity of PET and molecular imaging in radiation oncology may be built. The development of tools such as this is critical in order to realize the potential of molecular imagingguided radiation therapy.

[1]  N. Sadato,et al.  FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  B. Loo,et al.  Metabolic tumor volume as an independent prognostic factor in lymphoma , 2005 .

[3]  Elisabeth Kjellén,et al.  FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma , 2002, Head & neck.

[4]  M. Hata,et al.  FDG-PET scanning after radiation can predict tumor regrowth three months later. , 2003, International journal of radiation oncology, biology, physics.

[5]  S Mutic,et al.  A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. , 2001, International journal of radiation oncology, biology, physics.

[6]  Gábor Székely,et al.  Assessment of 18F PET signals for automatic target volume definition in radiotherapy treatment planning. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Philippe Lambin,et al.  The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. , 2006, Cancer treatment reviews.

[8]  Cyrill Burger,et al.  Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. , 2003, International journal of radiation oncology, biology, physics.

[9]  Cyrill Burger,et al.  Automated functional image-guided radiation treatment planning for rectal cancer. , 2005, International journal of radiation oncology, biology, physics.

[10]  Di Yan,et al.  Defining a radiotherapy target with positron emission tomography. , 2002, International journal of radiation oncology, biology, physics.

[11]  D Marr,et al.  Theory of edge detection , 1979, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[12]  H. Thierens,et al.  [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  David Schuster,et al.  Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. , 2005, International journal of radiation oncology, biology, physics.

[14]  Curtis B Caldwell,et al.  The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. , 2002, International journal of radiation oncology, biology, physics.

[15]  B. Loo,et al.  Metabolic Tumor Burden Predicts for Disease Progression in Lung Cancer , 2005 .

[16]  Cedric X. Yu,et al.  New Developments in Intensity Modulated Radiation Therapy , 2006, Technology in cancer research & treatment.

[17]  M Schwaiger,et al.  The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. , 1998, International journal of radiation oncology, biology, physics.

[18]  Wilson Roa,et al.  A local contrast based approach to threshold segmentation for PET target volume delineation. , 2006, Medical physics.

[19]  Radhe Mohan,et al.  Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking. , 2005, Medical physics.

[20]  G. V. von Schulthess,et al.  Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.